# OnCo record paper-mlsg15-mogamulizumab-atll-bjh-2015 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-mlsg15-mogamulizumab-atll-bjh-2015/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-mlsg15-mogamulizumab-atll-bjh-2015" ;
  schema:name "Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study"@en ;
  schema:alternateName "Ishida 2015"@en ;
  schema:description "Adding mogamulizumab to intensive chemotherapy for newly diagnosed adult T-cell leukaemia raised the complete remission rate from 33 to 52 per cent, with more side effects."@en ;
  schema:url <https://onco.cc/key-papers/paper-mlsg15-mogamulizumab-atll-bjh-2015/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.1111/bjh.13338>, <https://pubmed.ncbi.nlm.nih.gov/25733162/>, <https://europepmc.org/article/MED/25733162> ;
  onco:tag "lymphoma-evidence-entities" ;
  schema:sameAs <https://doi.org/10.1111/bjh.13338> ;
  schema:datePublished "2015"^^xsd:gYear ;
  schema:author "Ishida T, Jo T, Takemoto S, et al." ;
  onco:cancers <https://onco.cc/cancers/adult-t-cell-leukaemia-lymphoma/> ;
  onco:targets <https://onco.cc/targets/ccr4/> ;
  onco:drugs <https://onco.cc/drugs/mogamulizumab/> ;
  onco:trials <https://onco.cc/trials/mlsg15-mogamulizumab-atll/>, <https://onco.cc/trials/jcog9801/> .